| Date Filed | Type | Description |
| 10/03/2023 |
4
| Robinson James A. Jr. (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 150,437 options to buy
@ $1.55, valued at
$233.2k
|
|
| 10/03/2023 |
4
| Kirk Allan (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 150,437 options to buy
@ $1.55, valued at
$233.2k
|
|
| 10/02/2023 |
3
| Robinson James A. Jr. (Director) has filed a Form 3 on Eledon Pharmaceuticals, Inc. |
| 10/02/2023 |
3
| Kirk Allan (Director) has filed a Form 3 on Eledon Pharmaceuticals, Inc. |
| 05/09/2023 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Bought 1,055,445 shares
@ $0
Bought 837,146 shares
@ $0
Bought 86,341 shares
@ $0
Bought 2,028,645 options to buy
@ $0.001, valued at
$2k
Bought 1,609,063 options to buy
@ $0.001, valued at
$1.6k
Bought 165,950 options to buy
@ $0.001, valued at
$166
Bought 3,084,090 options to buy
@ $3, valued at
$9.3M
Bought 2,446,209 options to buy
@ $3, valued at
$7.3M
Bought 252,291 options to buy
@ $3, valued at
$756.9k
|
|
| 05/02/2023 |
4
| Smith Bryan E. (General Counsel, Corporate Sec) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 179,000 options to buy
@ $2.3, valued at
$411.7k
|
|
| 05/02/2023 |
4
| Perrin Steven (President) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 317,147 options to buy
@ $2.3, valued at
$729.4k
|
|
| 05/02/2023 |
4
| Gros David-Alexandre C (CEO) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 383,299 options to buy
@ $2.3, valued at
$881.6k
|
|
| 05/02/2023 |
4
| Ogier Walter C (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 150,437 options to buy
@ $2.3, valued at
$346k
|
|
| 05/02/2023 |
4
| Little Paul Sean (CFO) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 198,126 options to buy
@ $2.3, valued at
$455.7k
|
|
| 05/02/2023 |
4
| Katkin Keith (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 752,185 options to buy
@ $2.3, valued at
$1.7M
|
|
| 05/02/2023 |
4
| McBride John S. (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 150,437 options to buy
@ $2.3, valued at
$346k
|
|
| 05/02/2023 |
4
| LYONS GARY A (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 150,437 options to buy
@ $2.3, valued at
$346k
|
|
| 05/02/2023 |
4
| Lee June (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 150,437 options to buy
@ $2.3, valued at
$346k
|
|
| 05/02/2023 |
4
| Hillson Jan (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 150,437 options to buy
@ $2.3, valued at
$346k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Ogier Walter C (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $3.97, valued at
$79.4k
|
|
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|